Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R/SIRT1/GLUT4 pathway
Zhaojun Wang, Xinru Li, Shi-Fan Chai, et al.
Neuropharmacology (2023) Vol. 240, pp. 109716-109716
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson's and Alzheimer's disease clinical trials: A revolution in the making?
Christian Hölscher
Neuropharmacology (2024) Vol. 253, pp. 109952-109952
Open Access | Times Cited: 22
Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US
William Yang Wang, QuangQiu Wang, Xin Qi, et al.
Alzheimer s & Dementia (2024)
Open Access | Times Cited: 18
The GLP-1 Agonist Semaglutide Ameliorates Cognitive Regression in P301S Tauopathy Mice Model via Autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization
Norhan N. Elbadawy, Muhammed A. Saad, Sara Elfarrash, et al.
European Journal of Pharmacology (2025), pp. 177305-177305
Closed Access | Times Cited: 2
Pathogenesis, Diagnostics, and Therapeutics for Alzheimer's Disease: Breaking the Memory Barrier
Pushpa Tryphena Kamatham, Rashi K. Shukla, Dharmendra Kumar Khatri, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102481-102481
Open Access | Times Cited: 14
Anti-inflammatory benefits of semaglutide: State of the art
Habib Yaribeygi, Mina Maleki, Tannaz Jamialahmadi, et al.
Journal of Clinical & Translational Endocrinology (2024) Vol. 36, pp. 100340-100340
Open Access | Times Cited: 13
Exploring the Role of GLP-1 Receptor Agonists in Alzheimer’s Disease: A Review of Preclinical and Clinical Evidence
Lívia Cristina Ribeiro Teixeira, Marcelo R. Luizon, Karina Braga Gomes
Receptors (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access | Times Cited: 1
A Systematic Review of Semaglutide’s Influence on Cognitive Function in Preclinical Animal Models and Cell-Line Studies
Raluca Oana Tipa, Daniela-Gabriela Bălan, Mihai Géorgescu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4972-4972
Open Access | Times Cited: 7
Unlocking the Potential: Semaglutide’s Impact on Alzheimer’s and Parkinson’s Disease in Animal Models
Andreea-Daniela Meca, Ianis Kevyn Stefan Boboc, Liliana Mititelu-Tarţău, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5929-5949
Open Access | Times Cited: 4
All GLP-1 Agonists Should, Theoretically, Cure Alzheimer’s Dementia but Dulaglutide Might Be More Effective Than the Others
Jeffrey Fessel
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3729-3729
Open Access | Times Cited: 4
Target modulation of glycolytic pathways as a new strategy for the treatment of neuroinflammatory diseases
Hanlong Wang, Shasha Liu, Yang Sun, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102472-102472
Closed Access | Times Cited: 4
Reduction of Neuroinflammation as a Common Mechanism of Action of Anorexigenic and Orexigenic Peptide Analogues in the Triple Transgenic Mouse Model of Alzheimer´s Disease
Anna Mengr, Zuzana Šmotková, Andrea Pačesová, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Open Access
Navigating the Complexities of Neuronal Signaling and Targets in Neurological Disorders: From Pathology to Therapeutics
Divya Choudhary, Muhammad Imran Khan, Zuber Khan, et al.
European Journal of Pharmacology (2025), pp. 177417-177417
Closed Access
Semaglutide Ameliorates Neuroinflammation Caused by Enterogenous Pyrogen in APP/PS1 Mice
Yuan Yuan, Jiawei Zhang, Ziyao Zhang, et al.
Research Square (Research Square) (2025)
Closed Access
Effect and mechanism of GLP-1 on cognitive function in diabetes mellitus
Xiaoke Dou, Lei Zhao, Jing Li, et al.
Frontiers in Neuroscience (2025) Vol. 19
Open Access
Dipeptidyl peptidase-4 inhibitors enhance memory retention via neuropeptide Y
Iulia Zoicas, Stephan von Hörsten, Anne-Christine Plank, et al.
European Journal of Pharmacology (2025), pp. 177556-177556
Open Access
Semaglutide improves cognitive function and neuroinflammation in APP/PS1 transgenic mice by activating AMPK and inhibiting TLR4/NF-κB pathway
Yanyu Zhai, Kaili Lu, Yuan Yuan, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
GLP-1 receptor agonists efficacy in managing comorbidities associated with diabetes mellitus: a narrative review
Mahdi Gholami, Narges Zargar Balajam, Samira Rakhsha, et al.
Journal of Diabetes & Metabolic Disorders (2025) Vol. 24, Iss. 1
Closed Access
Semaglutide to remodel mitochondrial dynamics and mitophagy balance for vascular dementia therapy
Xiaoyan Yang, Peng Feng, Hongxu Zhu, et al.
View (2025)
Open Access
Incretin-based therapeutics for the treatment of neurodegenerative diseases
Anika Vear, Michael T. Heneka, Christoffer Clemmensen
Nature Metabolism (2025)
Closed Access
Elucidating the Role of Trem2 in Lipid Metabolism and Neuroinflammation
Chenhui Zhao, Wei Qi, Xiaoping Lv, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 4
Open Access
Role of Glucagon-Like Peptide-1 on Amyloid, Tau, and α-Synuclein: Target Engagement and Rationale for the Development in Neurodegenerative Disorders
Hezekiah C T Au, Rex Pui Kin Lam, Poh Khuen Lim, et al.
Neuroscience & Biobehavioral Reviews (2025), pp. 106159-106159
Open Access
Semaglutide alleviates early brain injury following subarachnoid hemorrhage by suppressing ferroptosis and neuroinflammation via SIRT1 pathway
Lei Chen, Haiting Xu, Chunlei Zhang, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 4, pp. 1102-1117
Open Access | Times Cited: 3
Potential New Therapeutic Implications of Semaglutide: New Colours of the Rainbow?
Evanthia Gouveri, Djordje S. Popovic, Νικόλαος Παπάνας
Diabetes Therapy (2023) Vol. 15, Iss. 1, pp. 13-18
Open Access | Times Cited: 7
GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for CombatingAlzheimer’s Disease through its Supporting DPP4 Inhibitors: A Review
Mohammad Abubakar, Lokesh Nama, Mohammad Arif Ansari, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 19, pp. 1635-1664
Closed Access | Times Cited: 2
Futoquinol improves Aβ25–35‐induced memory impairment in mice by inhibiting the activation of p38MAPK through the glycolysis pathway and regulating the composition of the gut microbiota
Yuhan Zhang, Hui Chen, Mengnan Zeng, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 4, pp. 1799-1814
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top